---
title: "ELTX.US (ELTX.US) — 相关新闻"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/ELTX.US/news.md"
symbol: "ELTX.US"
name: "ELTX.US"
parent: "https://longbridge.com/zh-CN/quote/ELTX.US.md"
datetime: "2026-03-12T00:19:21.619Z"
locales:
  - [en](https://longbridge.com/en/quote/ELTX.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ELTX.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ELTX.US/news.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/ELTX.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/ELTX.US/news.md)


# ELTX.US (ELTX.US) — 相关新闻

### [](https://longbridge.com/zh-CN/news/278595480.md)
*2026-03-10T17:13:33.000Z*
> Elicio Therapeutics shares are trading higher after Rodman & Renshaw initiated coverage on the stock with a Buy rating a

### [Eliem Therapeutics (NASDAQ:ELYM) Trading Down 2.8%  - Here's What Happened](https://longbridge.com/zh-CN/news/278501690.md)
*2026-03-10T06:34:53.000Z*
> Eliem Therapeutics (NASDAQ:ELYM) saw its stock price decline by 2.8% during trading on Monday, closing at $7.18 after re

### [Elicio Therapeutics To Issue Up To $400 Million In Securities](https://longbridge.com/zh-CN/news/277249742.md)
*2026-02-27T21:25:39.000Z*
> Feb 27 (Reuters) - Elicio Therapeutics Inc:* ELICIO THERAPEUTICS INC - TO ISSUE UP TO $400 MILLION IN SECURITIES - SEC F

### [ExCellThera secures German NUB Status 1 listing for Zemcelpro](https://longbridge.com/zh-CN/news/276111906.md)
*2026-02-17T09:31:11.000Z*
> ExCellThera has secured German NUB Status 1 listing for its therapy Zemcelpro, following positive clinical evidence and 

### [Eliem Therapeutics (NASDAQ:ELYM) Trading Up 1.1%  - Still a Buy?](https://longbridge.com/zh-CN/news/275876029.md)
*2026-02-13T09:13:18.000Z*
> Eliem Therapeutics (NASDAQ:ELYM) saw its stock price increase by 1.1% to $5.56 during trading, with a market cap of $165

### [U.S. stock market midday update: Elicio Therapeutics down 11.41%, trading volume increased, market sentiment fluctuations attract attention](https://longbridge.com/zh-CN/news/275502369.md)
*2026-02-10T19:07:55.000Z*
> Elicio Therapeutics fell 11.41%; AbbVie rose 0.77%, with a trading volume of USD 558 million; Gilead Sciences fell 1.40%

### [Elicio Therapeutics Grants Stock Options to New Employees](https://longbridge.com/zh-CN/news/269867022.md)
*2025-12-16T13:00:17.000Z*
> Elicio Therapeutics Inc. has granted 157,193 inducement stock options to three new employees, allowing them to purchase 

### [H.C. Wainwright Sticks to Its Buy Rating for Elicio Therapeutics (ELTX)](https://longbridge.com/zh-CN/news/266541823.md)
*2025-11-19T11:37:32.000Z*
> H.C. Wainwright's Robert Burns reiterated a Buy rating for Elicio Therapeutics (ELTX) with a $13.00 price target. Burns,